These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26672149)
1. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. Gossop M; Griffiths P; Powis B; Williamson S; Fountain J; Strang J AIDS Care; 1997 Dec; 9(6):651-60. PubMed ID: 26672149 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour. Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914 [TBL] [Abstract][Full Text] [Related]
3. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. Gossop M; Griffiths P; Powis B; Strang J AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Rhodes T; Davis M; Judd A Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237 [TBL] [Abstract][Full Text] [Related]
5. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Strang J; Griffiths P; Powis B; Gossop M Am J Addict; 1999; 8(2):148-60. PubMed ID: 10365195 [TBL] [Abstract][Full Text] [Related]
6. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975 [TBL] [Abstract][Full Text] [Related]
7. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854 [TBL] [Abstract][Full Text] [Related]
8. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Larance B; Degenhardt L; Copeland J; Dillon P Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549 [TBL] [Abstract][Full Text] [Related]
9. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Neaigus A; Miller M; Friedman SR; Hagen DL; Sifaneck SJ; Ildefonso G; des Jarlais DC Addiction; 2001 Jun; 96(6):847-60. PubMed ID: 11399216 [TBL] [Abstract][Full Text] [Related]
10. Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up. Gossop M; Marsden J; Stewart D; Kidd T Addict Behav; 2003 Jun; 28(4):785-93. PubMed ID: 12726791 [TBL] [Abstract][Full Text] [Related]
11. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits. Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677 [TBL] [Abstract][Full Text] [Related]
12. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Powis B; Strang J; Griffiths P; Taylor C; Williamson S; Fountain J; Gossop M Addiction; 1999 Apr; 94(4):471-8. PubMed ID: 10605843 [TBL] [Abstract][Full Text] [Related]
13. Gender differences in sharing injecting equipment by drug users in England. Bennett GA; Velleman RD; Barter G; Bradbury C AIDS Care; 2000 Feb; 12(1):77-87. PubMed ID: 10716020 [TBL] [Abstract][Full Text] [Related]
14. Behavioural change amongst drug injectors in Scottish prisons. Shewan D; Gemmell M; Davies JB Soc Sci Med; 1994 Dec; 39(11):1585-6. PubMed ID: 7817222 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Mathei C; Shkedy Z; Denis B; Kabali C; Aerts M; Molenberghs G; Van Damme P; Buntinx F J Viral Hepat; 2006 Aug; 13(8):560-70. PubMed ID: 16901287 [TBL] [Abstract][Full Text] [Related]
16. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection. Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L; Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554 [TBL] [Abstract][Full Text] [Related]
17. Sexual behaviour of drug injectors in London: implications for HIV transmission and HIV prevention. Rhodes T; Donoghoe M; Hunter G; Soteri A; Stimson GV Addiction; 1994 Sep; 89(9):1085-96. PubMed ID: 7987185 [TBL] [Abstract][Full Text] [Related]
18. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029 [TBL] [Abstract][Full Text] [Related]
19. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856 [TBL] [Abstract][Full Text] [Related]
20. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. Ross MW; McCurdy SA; Kilonzo GP; Williams ML; Leshabari MT Am J Trop Med Hyg; 2008 Sep; 79(3):338-43. PubMed ID: 18784224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]